Cefpodoxime
Cefpodoxime
CLINICAL USE
Antibacterial agent
DOSE IN NORMAL RENAL FUNCTION
100–200 mg every 12 hours
PHARMACOKINETICS
Molecular weight                           :557.6 (as proxetil) %Protein binding                           :20–40 %Excreted unchanged in urine     : 80 Volume of distribution (L/kg)       :0.6–1.2half-life – normal/ESRD (hrs)      :2.4/26 DOSE IN RENAL IMPAIRMENT
GFR (mL/MIN)
20 to 50     : Dose as in normal renal function 10 to 20     : Dose as in normal renal function <10           : 100–200 mg every 24 hours DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES
CAPD                :Not dialysed. Dose as in GFR <10 mL/min HD                     :Dialysed. Dose as in GFR <10           : mL/minHDF/high flux   :Dialysed. Dose as in GFR <10           : mL/minCAV/VVHD      :Dialysed. Dose as in normal renal function IMPORTANT DRUG INTERACTIONS
Potentially hazardous interactions with other drugsAnticoagulants: effects of coumarins may be enhanced ADMINISTRATION
Reconstition
– Route
Oral Rate of Administration
–Comments
Take with food Antacids and H 2-blockers should be taken 2–3 hours after administration of cefpodoxime.
See how to identify renal failure stages according to GFR calculation
See how to diagnose irreversible renal disease
Home